Multiple Pulmonary Nodules: Clinical Trials

5 trials for Multiple Pulmonary Nodules, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Unknown 1
Phase 11Completed 1

Follow Multiple Pulmonary Nodules: new trials by email Literature Review of Multiple Pulmonary Nodules trials Research Report on Multiple Pulmonary Nodules

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Limonene for Pulmonary Nodule Chemoprevention
Limonene capsule, Limonene capsules(Placebo) - Pulmonary Nodules
Phase 2UnknownShanghai Jiao Tong University School of Medicine1602023-02-012023-02-06
Neoadjuvant Immunotherapy in Early Stage Non-small-cell Lung Cancer Presenting as Synchronous Ground-glass Nodules
Tislelizumab Injection - Multiple Pulmonary Nodules
Phase 2CompletedXiangNing Fu122019-07-012025-09-23
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
Computed Tomography, Fludeoxyglucose F-18, Fluorine F 18 L-glutamate Derivative BAY94-9392 - Cigarette Smoker, Current Smoker
Phase 2CompletedAndrei Iagaru152019-02-042025-04-09
Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions
ICG Intervention, Near Infrared Camera - Pulmonary Nodule, Solitary, Pulmonary Nodule, Multiple
Phase 1 / Phase 2CompletedBrigham and Women's Hospital42016-02-012017-12-12
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules
Aspirin, Laboratory Biomarker Analysis, Placebo - Current Smoker, Former Smoker
Phase 2CompletedNational Cancer Institute (NCI)1092014-11-212020-05-21

Narrower conditions

Smoking Cessation (2)  ·  Lung Neoplasms (1)  ·  Solitary Pulmonary Nodule (1)  ·  Tobacco Use Disorder (1)

Broader conditions

Lung Diseases (5)  ·  Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Respiratory Tract Diseases (5)  ·  Respiratory Tract Neoplasms (5)  ·  Thoracic Neoplasms (5)  ·  Lung Neoplasms (4)  ·  Behavior (2)  ·  Health Behavior (2)  ·  Chemically-Induced Disorders (1)  ·  Mental Disorders (1)  ·  Substance-Related Disorders (1)

Interventions

4-(3-fluoropropyl)glutamic acid (1)  ·  Aspirin (1)  ·  Diagnostic Imaging (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Indocyanine Green (1)  ·  Limonene (1)  ·  Positron Emission Tomography Computed Tomography (1)  ·  Positron-Emission Tomography (1)  ·  Tomography (1)  ·  Tomography, X-Ray Computed (1)  ·  tislelizumab (1)

Sponsors

Andrei Iagaru (1)  ·  Brigham and Women's Hospital (1)  ·  National Cancer Institute (NCI) (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  XiangNing Fu (1)

Countries

United States (3)  ·  China (2)  ·  Italy (1)

Top investigators

Bernardo Bonanni (1)  ·  Biyun Qian, Doctor (1)  ·  Carina Mari Aparici (1)  ·  Rong Li, Doctor (1)  ·  Yolonda Colson, MD, PhD (1)

NIH funding

N01CN00034 (1), P30CA016672 (1)